Literature DB >> 14649781

Cognitive behavioural therapy for obesity: one-year follow-up in a clinical setting.

N Melchionda1, L Besteghi, S Di Domizio, F Pasqui, C Nuccitelli, S Migliorini, L Baraldi, S Natale, R Manini, M Bellini, C Belsito, G Forlani, G Marchesini.   

Abstract

Cognitive behavioural therapy (CBT) is the most comprehensive means of medically treating obesity, but only few data have so far been published concerning its long-term effectiveness. We here report our experience of 1068 consecutive patients (868 females) treated with CBT at a university-based obesity centre. The patients were enrolled into three different programmes: a 14-week LEARN programme (672 patients), a 16-week MOB programme for the morbidly obese (259 patients), or a 20-week BINGE programme for subjects affected by binge eating (137 patients). Eighty-five percent of the subjects completed the weekly programmes. The percentage of patients attending the scheduled control visits during the 1-year follow-up gradually decreased, being very low in the BINGE group (10%). The percentage weight loss was an average of 6% during the weekly courses, being higher in the MOB programme; by the end of the weekly sessions, it exceeded 10% of initial body weight in 22% of cases and increased to 36% during the follow-up. The cumulative probability of follow-up was higher among the patients undergoing the MOB and LEARN programmes than among the BINGE patients (p < 0.0001), and decreased with the increasing severity of obesity. Female gender and a weight loss of > 10% i.b.w. increased compliance to follow-up. The study further demonstrates the difficulty of achieving compliance to chronic management of obesity and the critical role of binge eating disorder in the medium-term treatment of obesity. Strategies are needed to improve adherence to a follow-up protocol.

Entities:  

Mesh:

Year:  2003        PMID: 14649781     DOI: 10.1007/bf03325012

Source DB:  PubMed          Journal:  Eat Weight Disord        ISSN: 1124-4909            Impact factor:   4.652


  30 in total

Review 1.  Cognitive-behavioural therapy for bulimia nervosa and binge eating disorder. A review.

Authors:  V Ricca; E Mannucci; T Zucchi; C M Rotella; C Faravelli
Journal:  Psychother Psychosom       Date:  2000 Nov-Dec       Impact factor: 17.659

2.  The SCL-90 and the MMPI: a step in the validation of a new self-report scale.

Authors:  L R Derogatis; K Rickels; A F Rock
Journal:  Br J Psychiatry       Date:  1976-03       Impact factor: 9.319

Review 3.  What is the role of cognitive-behavior therapy in patient management?

Authors:  J P Foreyt; W S Poston
Journal:  Obes Res       Date:  1998-04

Review 4.  Defining success in obesity management.

Authors:  S Rössner
Journal:  Int J Obes Relat Metab Disord       Date:  1997-03

Review 5.  Binge eating disorder: a review of the literature after publication of DSM-IV.

Authors:  D A Williamson; C K Martin
Journal:  Eat Weight Disord       Date:  1999-09       Impact factor: 4.652

6.  Strong and weak principles for progressing from precontemplation to action on the basis of twelve problem behaviors.

Authors:  J O Prochaska
Journal:  Health Psychol       Date:  1994-01       Impact factor: 4.267

7.  Long-term effects of modest weight loss in type II diabetic patients.

Authors:  R R Wing; R Koeske; L H Epstein; M P Nowalk; W Gooding; D Becker
Journal:  Arch Intern Med       Date:  1987-10

8.  One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

Authors:  N Finer; W P James; P G Kopelman; M E Lean; G Williams
Journal:  Int J Obes Relat Metab Disord       Date:  2000-03

9.  The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

Authors:  A J Stunkard; S Messick
Journal:  J Psychosom Res       Date:  1985       Impact factor: 3.006

Review 10.  Outpatient treatments of obesity: a comparison of methodology and clinical results.

Authors:  R R Wing; R W Jeffery
Journal:  Int J Obes       Date:  1979
View more
  7 in total

1.  Expected benefits and motivation to weight loss in relation to treatment outcomes in group-based cognitive-behavior therapy of obesity.

Authors:  Anna Simona Sasdelli; Maria Letizia Petroni; Anna Delli Paoli; Giulia Collini; Simona Calugi; Riccardo Dalle Grave; Giulio Marchesini
Journal:  Eat Weight Disord       Date:  2018-01-24       Impact factor: 4.652

2.  A short-term cognitive group treatment program gives substantial weight reduction up to 18 months from the end of treatment. A randomized controlled trial.

Authors:  L Stahre; T Hällström
Journal:  Eat Weight Disord       Date:  2005-03       Impact factor: 4.652

3.  Obesity treatment: results after 4 years of a Nutritional and Psycho-Physical Rehabilitation Program in an outpatient setting.

Authors:  Lorenzo M Donini; Massimo Cuzzolaro; Lucio Gnessi; Carla Lubrano; Silvia Migliaccio; Antonio Aversa; Alessandro Pinto; Andrea Lenzi
Journal:  Eat Weight Disord       Date:  2014-03-01       Impact factor: 4.652

4.  Personalized group cognitive behavioural therapy for obesity: a longitudinal study in a real-world clinical setting.

Authors:  Riccardo Dalle Grave; Simona Calugi; Giovanna Bosco; Luigi Valerio; Chiara Valenti; Marwan El Ghoch; Dante Zini
Journal:  Eat Weight Disord       Date:  2018-10-10       Impact factor: 4.652

5.  Combination of GLP-1 receptor agonists and behavioural treatment in type 2 diabetes elicits synergistic effects on body weight: A retrospective cohort study.

Authors:  Maria Letizia Petroni; Luca Montesi; Santo Colosimo; Maria Turchese Caletti; Arianna Mazzotti; Giulio Marchesini
Journal:  Endocrinol Diabetes Metab       Date:  2019-07-26

6.  Addressing motivation in globesity treatment: a new challenge for clinical psychology.

Authors:  Giada Pietrabissa; Gian Mauro Manzoni; Stefania Corti; Nadia Vegliante; Enrico Molinari; Gianluca Castelnuovo
Journal:  Front Psychol       Date:  2012-09-03

Review 7.  The vital link between chronic disease and depressive disorders.

Authors:  Daniel P Chapman; Geraldine S Perry; Tara W Strine
Journal:  Prev Chronic Dis       Date:  2004-12-15       Impact factor: 2.830

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.